Is iron deficiency in the absence of anemia associated with fatigue in inflammatory bowel disease?

American Journal of Gastroenterology

Volumn 108, Issue 9, 2013, Pages 1392-1397

  Goldenberg, Benjamin A ^a   Graff, Lesley A ^a   Clara, Ian ^a   Zarychanski, Ryan ^a   Walker, John R ^a   Carr, Rachel ^a   Rogala, Linda ^a   Miller, Norine ^a   Bernstein, Charles N ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEMOGLOBIN;

ACCURACY; ADULT; AGED; ARTICLE; CANADA; COHORT ANALYSIS; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; FATIGUE; FEMALE; FERRITIN BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON DEFICIENCY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA, IRON-DEFICIENCY; FATIGUE; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; IRON; MALE; MIDDLE AGED;

EID: 84883685092     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2013.14     Document Type: Article

References (49)

1. Swain MG. Fatigue in chronic disease. Clin Sci (Lond) 2000;99:1-8.
2. Hagelin CL, Wengstr? Y, Ahsberg E et al. Fatigue dimensions in patients with advanced cancer in relation to time of survival and quality of life. Palliat Med 2009;23:171-8.
3. Rupp I, Boshuizen HC, Jacobi CE et al. Impact of fatigue on health-related quality of life in rheumatoid arthritis. Arthritis Rheum 2004;51:578-85.
4. Krupp LB, Alvarez LA, LaRocca NG et al. Fatigue in multiple sclerosis. Arch Neurol 1988;45:435-7.
5. Van Langenberg DR, Gibson PR. Systematic review: fatigue in inflammatory bowel disease. Aliment Pharmacol Ther 2010;32:131-43.
6. Graff LA, Walker JR, Russell AS et al. Fatigue and quality of sleep in patients with immune-mediated inflammatory disease. J Rheumatol Suppl 2011;88:36-42.
7. Singh S, Blanchard A, Walker JR et al. Common symptoms and stressors among individuals with inflammatory bowel diseases. Clin Gastroenterol Hepatol 2011;9:769-75.
8. Graff LA, Vincent N, Walker JR et al. A population-based study of fatigue and sleep difficulties in inflammatory bowel disease. Inflamm Bowel Dis 2011;17:1882-9.
9. Romberg-Camps MJ, Bol Y, Dagnelie PC et al. Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort. Inflamm Bowel Dis 2010;16:2137-47.
10. Jelsness-J?gensen LP, Bernklev T, Henriksen M et al. Chronic fatigue is more prevalent in patients with inflammatory bowel disease than in healthy controls. Inflamm Bowel Dis 2011;17:1564-72.
11. Bager P, Befrits R, Wikman O et al. Fatigue in out-patients with inflammatory bowel disease is common and multifactorial. Aliment Pharmacol Ther 2012;35:133-41.
12. deRooy EC, Toner BB, Maunder RG et al. Concerns of patients with inflammatory bowel disease: results from a clinical population. Am J Gastroenterol 2001;96:1816-21.
13. Groopman JE, Itri LM. Chemotherapy-induced anemia in adults: incidence and treatment. J Natl Cancer Inst 1999;91:1616-34.
14. Crawford J, Cella D, Cleeland CS et al. Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetinalfa therapy. Cancer 2002;95:888-95.
15. Gasche C, Lomer MC, Cavill I et al. Iron, anemia, and inflammatory bowel diseases. Gut 2004;53:1190-7.
16. Weiss G, Gasche C. Pathogenesis and treatment of anemia in inflammatory bowel disease. Haematologica 2010;95:175-8.
17. Stein J, Hartmann F, Dignass AU. Iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol 2010;7:599-610.
18. Kullnigg S, Gasche C. Systemic review: managing anemia in Crohn's disease. Aliment Pharmacol Ther 2006;24:1507-23.
19. Gasche C, Berstad A, Befrits R et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007;13:1545-53.
20. Lakatos L, Pandur T, David G et al. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol 2003;9:2300-7.
21. Revel-Vilk S, Tamary H, Broide E et al. Serum transferrin receptor in children and adolescents with inflammatory bowel disease. Eur J Pediatr 2000;159:585-9.
22. Gasche C, Reinisch W, Lochs H et al. Anemia in Crohn's disease. Importance of inadequate erythropoietin production and iron deficiency. Dig Dis Sci 1994;39:1930-4.
23. Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997;89:1052-7.
24. Fernandez-Rodriguez AM, Guindeo-Casas? MC, Molero-Labarta T et al. Diagnosis of iron deficiency in chronic renal failure. Am J Kidney Dis 1999;34:508-13.
25. Ferguson BJ, Skikne BS, Simpson KM et al. Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia. J Lab Clin Med 1992;119:385-90.
26. Mast AE, Blinder MA, Gronowski AM et al. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem 1998;44:45-51.
27. Bernstein CN, Blanchard JF, Rawsthorne P et al. The epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol 1999;149:916-24.
28. Graff LA, Walker JR, Lix L et al. The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life. Clin Gastroenterol Hepatol 2006;4:1491-501.
29. Longobardi T, Walker JR, Graff LA et al. Health service utilization in IBD: comparison of self-report and administrative data. BMC Health Serv Res [online] 2011;11:137.
30. Harvey RF, Bradshaw JM. A simple index of Crohn's disease activity. Lancet 1980;1:514.
31. Powell-Tuck J, Brown RL, Lennard-Jones JE. A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis. Scand J Gastroenterol 1978;13:833-7.
32. Vermeire S, Schreiber S, Sandborn WJ et al. Correlations between the Crohn's Disease Activity and Harvey-Bradshaw indices in assessing Crohn's disease severity. Clin Gastroenterol Hepatol 2010;8:357-63.
33. Higgins PDR, Schwartz M, Mapili J et al. Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis. Gut 2005;54:782-8.
34. Smets EM, Garssen B, Bonke B et al. The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995;39:315-25.
35. Minderhoud IM, Oldenburg B, van Dam PS et al. High prevalence of fatigue in quiescent inflammatory bowel disease is not related to adrenocortical insufficiency. Am J Gastroenterol 2003;98:1088-93.
36. Guyatt GH, Oxman AD, Ali M et al. Laboratory diagnosis of iron-deficiency anemia: an overview. J Gen Intern Med 1992;7:145-53.
37. Chalder T, Berelowitz G, Pawlikowska T et al. Development of a fatigue scale. J Psychosom Res 1993;37:147-53.
38. Beutler E, Larsh SE, Gurney CW. Iron therapy in chronically fatigued, nonanaemic women: a double-blind study. Ann Intern Med 1960;52:378-94.
39. Elwood PC, Hughes D. Clinical trial of iron therapy on psychomotor function in anaemic women. Br Med J 1970;3:254-5.
40. Morrow J, Dagg J, Goldberg A. A controlled trial of iron therapy in sideropenia. Scott Med J 1968;13:78-83.
41. Dallman PR. Iron deficiency: does it matter? J Intern Med 1989;226:367-72.
42. Scrimshaw NS. Functional consequences or iron deficiency in human populations. J Nutr Sci Vitaminol (Tokyo) 1984;30:47-63.
43. Ballin A, Berar M, Rubinstein U et al. Iron state in female adolescents. Am J Dis Child 1992;146:803-5.
44. Verdon F, Burnand B, Stubi CL et al. Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomized placebo controlled trial. BMJ 2003;326:1124, doi:http://dx.doi.org/10.1136/bmj.326.7399.1124.
45. Patterson AJ, Brown WJ, Roberts DC. Dietary and supplement treatment of iron deficiency results in improvements in general health and fatigue in Australian women of childbearing age. J Am Coll Nutr 2001;20:337-42.
46. Krauenbuehl PA, Battegay E, Breymann C et al. Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration. Blood 2011;118:3222-7.
47. Bruner AB, Joffe A, Duggan A et al. Randomised study of cognitive effects of iron supplementation in non-anemic iron deficient adolescent girls. Lancet 1996;348:992-6.
48. Zarychanski R, Houston DS. Anemia of chronic disease: a harmful disorder or an adaptive, beneficial response? CMAJ 2008;179:333-7.
49. Jomova K, Valko M. Importance of iron chelation in free radical-induced oxidative stress and human disease. Curr Pharm Des 2011;17:3460-73.